Microbiota modulation of myeloid cells in cancer therapy

Cancer Immunol Res. 2015 Feb;3(2):103-9. doi: 10.1158/2326-6066.CIR-14-0225.

Abstract

Myeloid cells represent a major component of the tumor microenvironment, where they play divergent dual roles. They can induce antitumor immune responses, but mostly they promote immune evasion, tumor progression, and metastasis formation. Thus, strategies aiming at reprogramming the tumor microenvironment represent a promising immunotherapy approach. Myeloid cells respond to environmental factors including signals derived from commensal microbes. In this Cancer Immunology at the Crossroads overview, we discuss recent advances on the effects of the commensal microbiota on myeloid-cell functions and how they affect the response to cancer therapy.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation / immunology
  • Humans
  • Inflammation / immunology
  • Inflammation / microbiology
  • Microbiota / immunology*
  • Myeloid Cells / immunology*
  • Neoplasms / immunology
  • Neoplasms / microbiology
  • Neoplasms / therapy*
  • Symbiosis / immunology
  • Tumor Microenvironment / immunology